Nanocarrier Therapy for Treating Invasive Tumors

Liposomes of a size of less than 200 nanometers target tumors and preferentially deliver imipramine blue to tumors, including brain tumors such as gliomas. The imipramine blue decreases the invasiveness of the tumors, and inhibits tumor metastasis. The liposomes include cholesterol and chemically pure phospholipids that are essentially neutral and contain saturated fatty acids of between 16 and 18 carbon atoms, such as distearoylphosphatidyl choline, and can also include one or more pegylated phospholipids, such as DSPE-PEG.

Attached files:
WO 2010124004.jpg

Patents:
WO 2,010,124,004

Inventor(s): MUNSON JENNIFER M [US]; BELLAMKONDA RAVI V [US]; ARBISER JACK L [US]

Type of Offer: Licensing



Next Patent »
« More Nanotech Patents

Share on      


CrowdSell Your Patent